World Wires · story 5528 · unverified · 1 source(s)

Vivos Therapeutics reports cost reductions and revenue growth

Vivos Therapeutics announced plans to reduce annual overhead by $3.6 million while advancing revenue growth initiatives.

Open in the desk

Coverage

What this site indexes